Rockefeller Capital Management
PROK icon

Rockefeller Capital Management’s ProKidney PROK Stock Holding History

Rockefeller Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12
Closed -$29 – 4809
2025
Q3 		$29 Buy
+12
New +$32 ﹤0.01% 4404

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Rockefeller Capital Management's PROK Position: Q4 2025 in Review

Rockefeller Capital Management sold out of ProKidney (PROK) in Q4 2025, closing a stake of 12 shares — an estimated $29 sold.

Rockefeller Capital Management first reported a position in PROK in Q3 2025 and held it in 1 quarter. The position peaked at $29 in Q3 2025. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

  • Rockefeller Capital Management reported no remaining ProKidney position as of Q4 2025 after selling out during the quarter.
  • Rockefeller Capital Management sold 12 ProKidney shares in Q4 2025, an estimated $29.
  • Rockefeller Capital Management first reported a position in ProKidney in Q3 2025 and held it in 1 quarter.
  • Rockefeller Capital Management's ProKidney position peaked at $29 in Q3 2025.
  • 63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on Rockefeller Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.